SARMs are Selective Androgen Receptor Modulators, experimental therapeutic compounds with reduced androgenic properties that activate human androgen receptors in target tissues and are the subject of clinical studies on muscle wasting, bone density, growth hormone levels, blood flow, insulin sensitivity, fat burning, liver disease, muscle soreness, connective tissue healing, strength enhancement, weight loss, and many other applications. Scientists around the world are researching SARMs. Some studies have shown improvements in fat loss, muscle growth, strength levels, bone mineral density, faster recovery, and changes in the healing process. They are designed for building muscle mass but unlike anabolic steroids, their effects are selective to muscle tissue and body fat cells and they have minimal androgenic side effects.